Tag: Jie Zhang
Firms act on Ascendent’s USD1.66bn acquisition of Hollysys
Six firms advise on Ascendent Capital Partners' USD1.66bn acquisition of China's Hollysys Automation Technologies, a control system solutions provider
Six firms assist on AstraZeneca’s USD1.2bn Gracell purchase
Six firms act for parties involved with Anglo-Swedish pharmaceutical giant AstraZeneca’s acquisition of Chinese peer Gracell Biotechnologies for USD1.2 billion
Cooley, Davis Polk assist Chinese biopharma’s private placement
Cooley advises Gracell Biotechnologies, a Nasdaq-listed Chinese biopharmaceutical company, on its private placement financing of up to USD150 million
